| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from exercise of warrants | 132 | - |
| Net cash provided by financing activities | 5,260 | 1,816 |
| Effect of exchange rate changes on cash | -19 | 23 |
| Net change in cash and cash equivalents | -618 | -272 |
| Cash and cash equivalents at beginning of period | 2,338 | - |
| Cash and cash equivalents at end of period | 1,720 | - |
ARTELO BIOSCIENCES, INC. (ATLEW)
ARTELO BIOSCIENCES, INC. (ATLEW)